Brand against brand · semaglutide and tirzepatide

Wegovy vs Mounjaro

From the two FDA labels, read Published by PepVault

Wegovy is semaglutide, a GLP-1 receptor agonist, from Novo Nordisk; Mounjaro is tirzepatide, a GIP and GLP-1 receptor agonist, from Eli Lilly.

FDA approved Wegovy for weight loss and keeping it off, lowering heart risk in adults with heart disease and excess weight, and (the injection) the liver disease MASH. Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes.

Label against label

Wegovy and Mounjaro, from their FDA labels and Drugs@FDA
ComparedWegovyMounjaro
Active ingredientsemaglutidetirzepatide
ClassGLP-1 receptor agonistGIP and GLP-1 receptor agonist
MakerNovo NordiskEli Lilly
Approved forWeight reduction; heart risk with obesity; MASH (injection)Type 2 diabetes (adults and children 10 and up); heart risk
FormsSingle-dose pen; Single-dose syringe; FlexTouch pen; TabletSingle-dose pen or vial; Multi-dose vial or KwikPen
How oftenonce a week or once a dayonce a week
Starting dose0.25 mg a week (injection); 1.5 mg a day (tablets)2.5 mg a week
Top dose on the label7.2 mg a week (injection); 25 mg a day (tablets)15 mg a week
Most reported side effectNausea, 44% on 2.4 mg (placebo 16%)Nausea, 18% on 15 mg (placebo 4%)
Boxed warning“RISK OF THYROID C-CELL TUMORS”“RISK OF THYROID C-CELL TUMORS”
First approved20212022

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Wegovy injection, once a week

0.25 mg0.5 mg1 mg1.7 mg2.4 mg7.2 mgif needed
Wegovy’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Wegovy tablets, once a day

1.5 mg4 mg9 mg25 mg
Wegovy’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Mounjaro, once a week

2.5 mg5 mgif needed7.5 mgif needed10 mgif needed12.5 mgif needed15 mgif needed
Mounjaro’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.
A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

A missed dose, on each label

  • Wegovy: For a missed injection, the label looks at the next scheduled dose: more than 2 days away, take the missed one as soon as possible; less than 2 days away, skip it. Missing 2 or more weeks in a row means starting the climb again from a lower dose.
  • Mounjaro: A missed Mounjaro dose can still be given within 4 days (96 hours). After that it is skipped and the next one comes on the usual day.

The trial evidence

Questions

What is the difference between Wegovy and Mounjaro?

Wegovy is semaglutide, a GLP-1 receptor agonist; Mounjaro is tirzepatide, a GIP and GLP-1 receptor agonist. Their labels approve them for different uses and set different schedules.

What are Wegovy and Mounjaro approved for?

Wegovy is approved for weight loss and keeping it off, lowering heart risk in adults with heart disease and excess weight, and (the injection) the liver disease MASH. Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes.

How often are Wegovy and Mounjaro taken?

Wegovy is taken once a week or once a day, as an injection or a tablet; Mounjaro once a week, as an injection.

What are the dose ranges of Wegovy and Mounjaro?

On their labels, Wegovy runs 0.25 mg to 7.2 mg once a week or 1.5 mg to 25 mg once a day, and Mounjaro 2.5 mg to 15 mg once a week. A prescriber sets the actual dose.

What is the most common side effect of Wegovy and Mounjaro?

On Wegovy’s label: nausea, 44% on 2.4 mg (placebo 16%). On Mounjaro’s: nausea, 18% on 15 mg (placebo 4%).

Sources

PepVault is not affiliated with Novo Nordisk. Wegovy is a trademark of its owner. PepVault is not affiliated with Eli Lilly. Mounjaro is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo